Ledger.Open graph →
SEC Form D · filed August 4, 2025

Phio Pharmaceuticals Corp

Offering
$5.1M
Sold
$232K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KING OF PRUSSIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Robert A. Ferrara · Marlborough, MADirectorJonathan A. Freeman · KING OF PRUSSIA, PADirectorLisa A. Carson · KING OF PRUSSIA, PAExecRobert J. Bitterman · Marlborough, MAExec · DirectorCurtis A. Lockshin, Ph.D · KING OF PRUSSIA, PADirectorPatricia A. Bradford · KING OF PRUSSIA, PADirectorDavid H. Deming · KING OF PRUSSIA, PADirectorRobert A. Ferrara · Marlborough, MADirectorJonathan A. Freeman · KING OF PRUSSIA, PADirectorLisa A. Carson · KING OF PRUSSIA, PAExecRobert J. Bitterman · VILLANOVA, PAExec · DirectorDavid H. Deming · KING OF PRUSSIA, PADirectorCurtis A. Lockshin, Ph.D · KING OF PRUSSIA, PADirectorPatricia A. Bradford · KING OF PRUSSIA, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗